1     
CONTROLLED SUBSTANCES ACT AMENDMENTS

2     
2018 GENERAL SESSION

3     
STATE OF UTAH

4     
Chief Sponsor: Paul Ray

5     
Senate Sponsor: Allen M. Christensen

6     

7     LONG TITLE
8     General Description:
9          This bill modifies the Utah Controlled Substances Act.
10     Highlighted Provisions:
11          This bill:
12          ▸     adds certain substances to the lists of controlled substances and Schedule I
13     controlled substances; and
14          ▸     makes technical changes.
15     Money Appropriated in this Bill:
16          None
17     Other Special Clauses:
18          None
19     Utah Code Sections Affected:
20     AMENDS:
21          58-37-4, as last amended by Laws of Utah 2017, Chapters 172 and 432
22          58-37-4.2, as last amended by Laws of Utah 2017, Chapter 172
23     

24     Be it enacted by the Legislature of the state of Utah:
25          Section 1. Section 58-37-4 is amended to read:
26          58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
27     required -- Specific substances included in schedules.
28          (1) There are established five schedules of controlled substances known as Schedules I,
29     II, III, IV, and V which consist of substances listed in this section.
30          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
31     the official name, common or usual name, chemical name, or brand name designated:
32          (a) Schedule I:
33          (i) Unless specifically excepted or unless listed in another schedule, any of the
34     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
35     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
36     chemical designation:
37          (A) Acetyl-alpha-methylfentanyl
38     (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
39          (B) Acetyl fentanyl: (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
40          (C) Acetylmethadol;
41          (D) Acryl fentanyl (N-(1-Phenethylpiperidin-4-yl)-N-phenylacrylamide);
42          [(D)] (E) Allylprodine;
43          [(E)] (F) Alphacetylmethadol, except levo-alphacetylmethadol also known as
44     levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
45          [(F)] (G) Alphameprodine;
46          [(G)] (H) Alphamethadol;
47          [(H)] (I) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
48     propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
49          [(I)] (J) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
50     piperidinyl]-N-phenylpropanamide);
51          [(J)] (K) Benzylpiperazine;
52          [(K)] (L) Benzethidine;
53          [(L)] (M) Betacetylmethadol;
54          [(M)] (N) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
55     piperidinyl]-N-phenylpropanamide);
56          [(N)] (O) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
57     phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
58          [(O)] (P) Betameprodine;
59          [(P)] (Q) Betamethadol;
60          [(Q)] (R) Betaprodine;
61          [(R)] (S) Butyryl fentanyl[:] (N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylbutyramide);
62          [(S)] (T) Clonitazene;
63          (U) Cyclopropyl fentanyl
64     (N-(1-Phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
65          [(T)] (V) Dextromoramide;
66          [(U)] (W) Diampromide;
67          [(V)] (X) Diethylthiambutene;
68          [(W)] (Y) Difenoxin;
69          [(X)] (Z) Dimenoxadol;
70          [(Y)] (AA) Dimepheptanol;
71          [(Z)] (BB) Dimethylthiambutene;
72          [(AA)] (CC) Dioxaphetyl butyrate;
73          [(BB)] (DD) Dipipanone;
74          [(CC)] (EE) Ethylmethylthiambutene;
75          (FF) Etizolam
76     (1-Methyl-6-o-chlorophenyl-8-ethyl-4H-s-triazolo[3,4-c]thieno[2,3-e]1,4-diazepine);
77          [(DD)] (GG) Etonitazene;
78          [(EE)] (HH) Etoxeridine;
79          [(FF)] (II) Furanyl fentanyl[:] (N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]
80     furan-2-carboxamide);
81          [(GG)] (JJ) Furethidine;
82          [(HH)] (KK) Hydroxypethidine;
83          [(II)] (LL) Ketobemidone;
84          [(JJ)] (MM) Levomoramide;
85          [(KK)] (NN) Levophenacylmorphan;
86          (OO) Methoxyacetyl fentanyl
87     (2-Methoxy-N-(1-phenylethylpiperidinyl-4-yl)-N-acetamide);
88          [(LL)] (PP) Morpheridine;
89          [(MM)] (QQ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
90          [(NN)] (RR) Noracymethadol;
91          [(OO)] (SS) Norlevorphanol;
92          [(PP)] (TT) Normethadone;
93          [(QQ)] (UU) Norpipanone;
94          [(RR)] (VV) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-
95     piperidinyl] propanamide);
96          (WW) Para-fluoroisobutyryl fentanyl
97     (N-(4-Fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
98          [(SS)] (XX) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
99          [(TT)] (YY) Phenadoxone;
100          [(UU)] (ZZ) Phenampromide;
101          [(VV)] (AAA) Phenomorphan;
102          [(WW)] (BBB) Phenoperidine;
103          [(XX)] (CCC) Piritramide;
104          [(YY)] (DDD) Proheptazine;
105          [(ZZ)] (EEE) Properidine;
106          [(AAA)] (FFF) Propiram;
107          [(BBB)] (GGG) Racemoramide;
108          (HHH) Tetrahydrofuran fentanyl
109     (N-(1-Phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
110          [(CCC)] (III) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
111     propanamide;
112          [(DDD)] (JJJ) Tilidine;
113          [(EEE)] (KKK) Trimeperidine;
114          [(FFF)] (LLL) 3-methylfentanyl, including the optical and geometric isomers
115     (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide);
116          [(GGG)] (MMM) 3-methylthiofentanyl
117     (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide); [and]
118          [(HHH)] (NNN) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide
119     also known as U-47700[.]; and
120          (OOO) 4-cyano CUMYL-BUTINACA.
121          (ii) Unless specifically excepted or unless listed in another schedule, any of the
122     following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
123     salts, isomers, and salts of isomers is possible within the specific chemical designation:
124          (A) Acetorphine;
125          (B) Acetyldihydrocodeine;
126          (C) Benzylmorphine;
127          (D) Codeine methylbromide;
128          (E) Codeine-N-Oxide;
129          (F) Cyprenorphine;
130          (G) Desomorphine;
131          (H) Dihydromorphine;
132          (I) Drotebanol;
133          (J) Etorphine (except hydrochloride salt);
134          (K) Heroin;
135          (L) Hydromorphinol;
136          (M) Methyldesorphine;
137          (N) Methylhydromorphine;
138          (O) Morphine methylbromide;
139          (P) Morphine methylsulfonate;
140          (Q) Morphine-N-Oxide;
141          (R) Myrophine;
142          (S) Nicocodeine;
143          (T) Nicomorphine;
144          (U) Normorphine;
145          (V) Pholcodine; and
146          (W) Thebacon.
147          (iii) Unless specifically excepted or unless listed in another schedule, any material,
148     compound, mixture, or preparation which contains any quantity of the following hallucinogenic
149     substances, or which contains any of their salts, isomers, and salts of isomers when the
150     existence of the salts, isomers, and salts of isomers is possible within the specific chemical
151     designation; as used in this Subsection (2)(a)(iii) only, "isomer" includes the optical, position,
152     and geometric isomers:
153          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
154     α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET;
155          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
156     4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA;
157          (C) 4-bromo-2,5-dimethoxyphenethylamine, some trade or other names:
158     2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
159          (D) 2,5-dimethoxyamphetamine, some trade or other names:
160     2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA;
161          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
162          (F) 4-methoxyamphetamine, some trade or other names:
163     4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA;
164          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
165          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
166     4-methyl-2,5-dimethoxy-α-methylphenethylamine; "DOM"; and "STP";
167          (I) 3,4-methylenedioxy amphetamine;
168          (J) 3,4-methylenedioxymethamphetamine (MDMA);
169          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
170     alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
171          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
172     N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
173          (M) 3,4,5-trimethoxy amphetamine;
174          (N) Bufotenine, some trade and other names:
175     3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
176     N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
177          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
178          (P) Dimethyltryptamine, some trade or other names: DMT;
179          (Q) Ibogaine, some trade and other names:
180     7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
181     [5,4-b] indole; Tabernanthe iboga;
182          (R) Lysergic acid diethylamide;
183          (S) Marijuana;
184          (T) Mescaline;
185          (U) Parahexyl, some trade or other names:
186     3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
187          (V) Peyote, meaning all parts of the plant presently classified botanically as
188     Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
189     any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
190     preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
191          (W) N-ethyl-3-piperidyl benzilate;
192          (X) N-methyl-3-piperidyl benzilate;
193          (Y) Psilocybin;
194          (Z) Psilocyn;
195          (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
196     (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis
197     plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
198     and their isomers with similar chemical structure and pharmacological activity to those
199     substances contained in the plant, such as the following: Δ1 cis or trans tetrahydrocannabinol,
200     and their optical isomers Δ6 cis or trans tetrahydrocannabinol, and their optical isomers Δ3,4
201     cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
202     substances is not internationally standardized, compounds of these structures, regardless of
203     numerical designation of atomic positions covered;
204          (BB) Ethylamine analog of phencyclidine, some trade or other names:
205     N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
206     N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
207          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
208     1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
209          (DD) Thiophene analog of phencyclidine, some trade or other names:
210     1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
211          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
212          (iv) Unless specifically excepted or unless listed in another schedule, any material
213     compound, mixture, or preparation which contains any quantity of the following substances
214     having a depressant effect on the central nervous system, including its salts, isomers, and salts
215     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
216     specific chemical designation:
217          (A) Mecloqualone; and
218          (B) Methaqualone.
219          (v) Any material, compound, mixture, or preparation containing any quantity of the
220     following substances having a stimulant effect on the central nervous system, including their
221     salts, isomers, and salts of isomers:
222          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
223     4,5-dihydro-5-phenyl-2-oxazolamine;
224          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
225     alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
226          (C) Fenethylline;
227          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
228     alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
229     alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
230     methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
231     optical isomers;
232          (E) (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
233          (F) N-ethylamphetamine; and
234          (G) N,N-dimethylamphetamine, also known as
235     N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
236          (vi) Any material, compound, mixture, or preparation which contains any quantity of
237     the following substances, including their optical isomers, salts, and salts of isomers, subject to
238     temporary emergency scheduling:
239          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
240          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
241          (vii) Unless specifically excepted or unless listed in another schedule, any material,
242     compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
243     (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
244          (b) Schedule II:
245          (i) Unless specifically excepted or unless listed in another schedule, any of the
246     following substances whether produced directly or indirectly by extraction from substances of
247     vegetable origin, or independently by means of chemical synthesis, or by a combination of
248     extraction and chemical synthesis:
249          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
250     opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
251     and their respective salts, but including:
252          (I) Raw opium;
253          (II) Opium extracts;
254          (III) Opium fluid;
255          (IV) Powdered opium;
256          (V) Granulated opium;
257          (VI) Tincture of opium;
258          (VII) Codeine;
259          (VIII) Ethylmorphine;
260          (IX) Etorphine hydrochloride;
261          (X) Hydrocodone;
262          (XI) Hydromorphone;
263          (XII) Metopon;
264          (XIII) Morphine;
265          (XIV) Oxycodone;
266          (XV) Oxymorphone; and
267          (XVI) Thebaine;
268          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
269     identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
270     substances may not include the isoquinoline alkaloids of opium;
271          (C) Opium poppy and poppy straw;
272          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
273     any salt, compound, derivative, or preparation which is chemically equivalent or identical with
274     any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
275     and salts of isomers and derivatives, whether derived from the coca plant or synthetically
276     produced, except the substances may not include decocainized coca leaves or extraction of coca
277     leaves, which extractions do not contain cocaine or ecgonine; and
278          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
279     liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
280          (ii) Unless specifically excepted or unless listed in another schedule, any of the
281     following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
282     ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
283     chemical designation, except dextrorphan and levopropoxyphene:
284          (A) Alfentanil;
285          (B) Alphaprodine;
286          (C) Anileridine;
287          (D) Bezitramide;
288          (E) Bulk dextropropoxyphene (nondosage forms);
289          (F) Carfentanil;
290          (G) Dihydrocodeine;
291          (H) Diphenoxylate;
292          (I) Fentanyl;
293          (J) Isomethadone;
294          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
295     levomethadyl acetate, or LAAM;
296          (L) Levomethorphan;
297          (M) Levorphanol;
298          (N) Metazocine;
299          (O) Methadone;
300          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
301          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
302     acid;
303          (R) Pethidine (meperidine);
304          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
305          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
306          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
307          (V) Phenazocine;
308          (W) Piminodine;
309          (X) Racemethorphan;
310          (Y) Racemorphan;
311          (Z) Remifentanil; and
312          (AA) Sufentanil.
313          (iii) Unless specifically excepted or unless listed in another schedule, any material,
314     compound, mixture, or preparation which contains any quantity of the following substances
315     having a stimulant effect on the central nervous system:
316          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
317          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
318          (C) Phenmetrazine and its salts; and
319          (D) Methylphenidate.
320          (iv) Unless specifically excepted or unless listed in another schedule, any material,
321     compound, mixture, or preparation which contains any quantity of the following substances
322     having a depressant effect on the central nervous system, including its salts, isomers, and salts
323     of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
324     specific chemical designation:
325          (A) Amobarbital;
326          (B) Glutethimide;
327          (C) Pentobarbital;
328          (D) Phencyclidine;
329          (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
330     1-piperidinocyclohexanecarbonitrile (PCC); and
331          (F) Secobarbital.
332          (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
333     compound, mixture, or preparation which contains any quantity of Phenylacetone.
334          (B) Some of these substances may be known by trade or other names:
335     phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
336          (vi) Nabilone, another name for nabilone:
337     (±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
338     6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
339          (c) Schedule III:
340          (i) Unless specifically excepted or unless listed in another schedule, any material,
341     compound, mixture, or preparation which contains any quantity of the following substances
342     having a stimulant effect on the central nervous system, including its salts, isomers whether
343     optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
344     and salts of isomers is possible within the specific chemical designation:
345          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
346     stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
347     listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
348     Code of Federal Regulations, and any other drug of the quantitive composition shown in that
349     list for those drugs or which is the same except that it contains a lesser quantity of controlled
350     substances;
351          (B) Benzphetamine;
352          (C) Chlorphentermine;
353          (D) Clortermine; and
354          (E) Phendimetrazine.
355          (ii) Unless specifically excepted or unless listed in another schedule, any material,
356     compound, mixture, or preparation which contains any quantity of the following substances
357     having a depressant effect on the central nervous system:
358          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
359     pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
360     which are not listed in any schedule;
361          (B) Any suppository dosage form containing amobarbital, secobarbital, or
362     pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
363     Administration for marketing only as a suppository;
364          (C) Any substance which contains any quantity of a derivative of barbituric acid or any
365     salt of any of them;
366          (D) Chlorhexadol;
367          (E) Buprenorphine;
368          (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
369     isomers, and salts of isomers, for which an application is approved under the federal Food,
370     Drug, and Cosmetic Act, Section 505;
371          (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
372     ± -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
373          (H) Lysergic acid;
374          (I) Lysergic acid amide;
375          (J) Methyprylon;
376          (K) Sulfondiethylmethane;
377          (L) Sulfonethylmethane;
378          (M) Sulfonmethane; and
379          (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
380     tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
381     2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
382     4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
383     flupyrazapon.
384          (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
385     U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
386     (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
387     (-)-delta-9-(trans)-tetrahydrocannabinol.
388          (iv) Nalorphine.
389          (v) Unless specifically excepted or unless listed in another schedule, any material,
390     compound, mixture, or preparation containing limited quantities of any of the following
391     narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
392          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
393     milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
394     opium;
395          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
396     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
397     therapeutic amounts;
398          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
399     than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
400     alkaloid of opium;
401          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
402     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
403     recognized therapeutic amounts;
404          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
405     milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
406     therapeutic amounts;
407          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
408     than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
409     recognized therapeutic amounts;
410          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
411     more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
412     recognized therapeutic amounts; and
413          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
414     one or more active, non-narcotic ingredients in recognized therapeutic amounts.
415          (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
416     including any of the following or any isomer, ester, salt, or derivative of the following that
417     promotes muscle growth:
418          (A) Boldenone;
419          (B) Chlorotestosterone (4-chlortestosterone);
420          (C) Clostebol;
421          (D) Dehydrochlormethyltestosterone;
422          (E) Dihydrotestosterone (4-dihydrotestosterone);
423          (F) Drostanolone;
424          (G) Ethylestrenol;
425          (H) Fluoxymesterone;
426          (I) Formebulone (formebolone);
427          (J) Mesterolone;
428          (K) Methandienone;
429          (L) Methandranone;
430          (M) Methandriol;
431          (N) Methandrostenolone;
432          (O) Methenolone;
433          (P) Methyltestosterone;
434          (Q) Mibolerone;
435          (R) Nandrolone;
436          (S) Norethandrolone;
437          (T) Oxandrolone;
438          (U) Oxymesterone;
439          (V) Oxymetholone;
440          (W) Stanolone;
441          (X) Stanozolol;
442          (Y) Testolactone;
443          (Z) Testosterone; and
444          (AA) Trenbolone.
445          (vii) Anabolic steroids expressly intended for administration through implants to cattle
446     or other nonhuman species, and approved by the Secretary of Health and Human Services for
447     use, may not be classified as a controlled substance.
448          (d) Schedule IV:
449          (i) Unless specifically excepted or unless listed in another schedule, any material,
450     compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
451     less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
452          (ii) Unless specifically excepted or unless listed in another schedule, any material,
453     compound, mixture, or preparation which contains any quantity of the following substances,
454     including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
455     salts of isomers is possible within the specific chemical designation:
456          (A) Alprazolam;
457          (B) Barbital;
458          (C) Bromazepam;
459          (D) Butorphanol;
460          (E) Camazepam;
461          (F) Carisoprodol;
462          (G) Chloral betaine;
463          (H) Chloral hydrate;
464          (I) Chlordiazepoxide;
465          (J) Clobazam;
466          (K) Clonazepam;
467          (L) Clorazepate;
468          (M) Clotiazepam;
469          (N) Cloxazolam;
470          (O) Delorazepam;
471          (P) Diazepam;
472          (Q) Dichloralphenazone;
473          (R) Estazolam;
474          (S) Ethchlorvynol;
475          (T) Ethinamate;
476          (U) Ethyl loflazepate;
477          (V) Fludiazepam;
478          (W) Flunitrazepam;
479          (X) Flurazepam;
480          (Y) Halazepam;
481          (Z) Haloxazolam;
482          (AA) Ketazolam;
483          (BB) Loprazolam;
484          (CC) Lorazepam;
485          (DD) Lormetazepam;
486          (EE) Mebutamate;
487          (FF) Medazepam;
488          (GG) Meprobamate;
489          (HH) Methohexital;
490          (II) Methylphenobarbital (mephobarbital);
491          (JJ) Midazolam;
492          (KK) Nimetazepam;
493          (LL) Nitrazepam;
494          (MM) Nordiazepam;
495          (NN) Oxazepam;
496          (OO) Oxazolam;
497          (PP) Paraldehyde;
498          (QQ) Pentazocine;
499          (RR) Petrichloral;
500          (SS) Phenobarbital;
501          (TT) Pinazepam;
502          (UU) Prazepam;
503          (VV) Quazepam;
504          (WW) Temazepam;
505          (XX) Tetrazepam;
506          (YY) Triazolam;
507          (ZZ) Zaleplon; and
508          (AAA) Zolpidem.
509          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
510     any quantity of the following substances, including its salts, isomers whether optical, position,
511     or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
512     isomers is possible.
513          (iv) Unless specifically excepted or unless listed in another schedule, any material,
514     compound, mixture, or preparation which contains any quantity of the following substances
515     having a stimulant effect on the central nervous system, including its salts, isomers whether
516     optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
517     isomers, and salts of isomers is possible within the specific chemical designation:
518          (A) Cathine ((+)-norpseudoephedrine);
519          (B) Diethylpropion;
520          (C) Fencamfamine;
521          (D) Fenproprex;
522          (E) Mazindol;
523          (F) Mefenorex;
524          (G) Modafinil;
525          (H) Pemoline, including organometallic complexes and chelates thereof;
526          (I) Phentermine;
527          (J) Pipradrol;
528          (K) Sibutramine; and
529          (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
530          (v) Unless specifically excepted or unless listed in another schedule, any material,
531     compound, mixture, or preparation which contains any quantity of dextropropoxyphene
532     (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
533          (e) Schedule V:
534          (i) Any compound, mixture, or preparation containing any of the following limited
535     quantities of narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid,
536     which includes one or more non-narcotic active medicinal ingredients in sufficient proportion
537     to confer upon the compound, mixture, or preparation valuable medicinal qualities other than
538     those possessed by the narcotic drug alone:
539          (A) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
540          (B) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
541     grams;
542          (C) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
543     grams;
544          (D) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
545     atropine sulfate per dosage unit;
546          (E) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
547          (F) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
548     atropine sulfate per dosage unit;
549          (G) unless specifically exempted or excluded or unless listed in another schedule, any
550     material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
551     effect on the central nervous system, including its salts, isomers, and salts of isomers; and
552          (H) all forms of Tramadol.
553           (ii) Cannabidiol in a drug product that is approved by the United States Food and Drug
554     Administration.
555          Section 2. Section 58-37-4.2 is amended to read:
556          58-37-4.2. Listed controlled substances.
557          The following substances, their analogs, homologs, and synthetic equivalents are listed
558     controlled substances:
559          (1) AB-001;
560          (2) AB-PINACA;
561     N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;
562          (3) AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl)
563     methyl]-1H-indazole-3-carboxamide;
564          (4) AB-CHMINACA
565     (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
566          [(4)] (5) ADB-CHMINACA[:] (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-
567     (cyclohexylmethyl)indazole-3-carboxamide);
568          [(5)] (6) ADB-FUBINACA[:] (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1-
569     (4-fluorobenzyl)-1H-indazole-3-caboxamide);
570          [(6)] (7) AKB48;
571          (8) alpha-Pyrrolidinohexanophenone (alpha-PHP)
572     (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one);
573          [(7)] (9) alpha-Pyrrolidinovalerophenone (alpha-PVP);
574          [(8)] (10) AM-694[;] (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone);
575          [(9)] (11) AM-1248;
576          [(10)] (12) AM-2201[;] (1-(5-fluoropentyl)-3-(1-naphthoyl)indole);
577          [(11)] (13) AM-2233;
578          [(12)] (14) AM-679;
579          [(13)] (15) A796,260;
580          [(14)] (16) Butylone;
581          [(15)] (17) CP 47,497 and its C6, C8, and C9 homologs[;]
582     (2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol);
583          [(16)] (18) Diisopropyltryptamine (DiPT);
584          [(17)] (19) Ethylone;
585          [(18)] (20) Ethylphenidate;
586          [(19)] (21) Fluoroisocathinone;
587          [(20)] (22) Fluoromethamphetamine;
588          [(21)] (23) Fluoromethcathinone;
589          [(22)] (24) FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate;
590          [(23)] (25) HU-210;
591     (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
592     -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
593          [(24)] (26) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
594     methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
595          [(25)] (27) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
596          [(26)] (28) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
597     1-Pentyl-3-(1-naphthoyl)indole};
598          [(27)] (29) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
599          [(28)] (30) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
600     1-Butyl-3-(1-naphthoyl)indole};
601          [(29)] (31) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
602          [(30)] (32) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
603          [(31)] (33) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
604          [(32)] (34) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
605          [(33)] (35) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
606          [(34)] (36) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
607          [(35)] (37) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
608          [(36)] (38) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;
609          [(37)] (39) MAM-2201;
610          [(38)] (40) MAM-2201;
611     (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;
612          [(39)] (41) Methoxetamine;
613          [(40)] (42) Naphyrone;
614          [(41)] (43) PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;
615          [(42)] (44) Pentedrone;
616          [(43)] (45) Pentylone;
617          [(44)] (46) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
618          [(45)] (47) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
619     known as BTW-8 and SR-18};
620          [(46)] (48) STS-135;
621          [(47)] (49) UR-144;
622          [(48)] (50) UR-144 N-(5-chloropentyl) analog;
623          [(49)] (51) XLR11;
624          [(50)] (52) 2C-C;
625          [(51)] (53) 2C-D;
626          [(52)] (54) 2C-E;
627          [(53)] (55) 2C-H;
628          [(54)] (56) 2C-I;
629          [(55)] (57) 2C-N;
630          [(56)] (58) 2C-P;
631          [(57)] (59) 2C-T-2;
632          [(58)] (60) 2C-T-4;
633          [(59)] (61) 2NE1;
634          [(60)] (62) 25I-NBOMe;
635          [(61)] (63) 2,5-Dimethoxy-4-chloroamphetamine (DOC);
636          [(62)] (64) 4-methylmethcathinone {also known as mephedrone};
637          [(63)] (65) 3,4-methylenedioxypyrovalerone {also known as MDPV};
638          [(64)] (66) 3,4-Methylenedioxymethcathinone {also known as methylone};
639          [(65)] (67) 4-methoxymethcathinone;
640          [(66)] (68) 4-Methyl-alpha-pyrrolidinopropiophenone;
641          [(67)] (69) 4-Methylethcathinone;
642          [(68)] (70) 5F-AKB48;
643     1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;
644          (71) 5-Fluoro ADB (Methyl
645     N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methyl-valinate);
646          (72) 5-Fluoro AMB (Methyl
647     N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate);
648          [(69)] (73) 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid
649     8-quinolinyl ester;
650          [(70)] (74) 5-Iodo-2-aminoindane (5-IAI);
651          [(71)] (75) 5-MeO-DALT;
652          [(72)] (76) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
653     methyl]ethanamine;
654          [(73)] (77) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
655     methyl]ethanamine; and
656          [(74)] (78) 25H-NBOMe;
657     2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.




Legislative Review Note
Office of Legislative Research and General Counsel